Industry News
Cancer researchers discover root cause of multiple myeloma relapse
Sep 12, 2013
Clinical researchers at Princess Margaret Cancer Centre have discovered why multiple myeloma, an incurable cancer of the bone marrow, persistently escapes cure by an initially effective treatment that can keep the disease at bay for up to several years... Read More
Chemists find new way to put the brakes on cancer
Sep 12, 2013
While great strides have been achieved in cancer treatment, scientists are looking for the new targets and next generation of therapeutics to stop this second leading cause of death nationwide. A new platform for drug discovery has been developed through a collaborative effort linking chemists at NYU and pharmacologists at USC... Read More
New study reveals patients are missing out on essential palliative care
Sep 11, 2013
New research published[1] on Monday 9 September from researchers at Marie Curie Cancer Care, the University of Edinburgh and NHS Lothian, reveals that only 20% of non-cancer patients are receiving palliative care before dying... Read More
NCI scientists identify targets for melanoma immunotherapy
Sep 10, 2013
Using a highly sensitive technology called NanoString, researchers have identified seven targets that could potentially be used to develop new immunotherapies for patients with metastatic melanoma, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research... Read More
NCI scientists identify targets for melanoma immunotherapy
Sep 10, 2013
Using a highly sensitive technology called NanoString, researchers have identified seven targets that could potentially be used to develop new immunotherapies for patients with metastatic melanoma, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research... Read More
Moffitt Cancer Center study aims to improve colorectal cancer screening rates among black men and women
Sep 10, 2013
Moffitt Cancer Center is recruiting participants for a study aimed at reducing ethnic disparities in colorectal cancer screening. Colorectal cancer is the third leading cancer killer in the United States, despite its detectability and preventability. Low screening rates are a factor, especially among black men and women; a group that has the highest incidence of colorectal cancer... Read More
Moffitt Cancer Center study aims to improve colorectal cancer screening rates among black men and women
Sep 10, 2013
Moffitt Cancer Center is recruiting participants for a study aimed at reducing ethnic disparities in colorectal cancer screening. Colorectal cancer is the third leading cancer killer in the United States, despite its detectability and preventability. Low screening rates are a factor, especially among black men and women; a group that has the highest incidence of colorectal cancer... Read More
Researchers uncover genetic cause of childhood leukemia
Sep 10, 2013
For the first time, a genetic link specific to risk of childhood leukemia has been identified, according to a team of researchers from Memorial Sloan-Kettering Cancer Center, St. Jude Children's Research Hospital, University of Washington, and other institutions. The discovery was reported online in the journal Nature Genetics... Read More
Bone growth factor may increase benign tumors but not malignant cancer
Sep 10, 2013
Patients undergoing spinal fusion surgery with bone morphogenetic protein (BMP) appear to be at increased risk of benign tumors - but not cancers, reports a study in the September issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health... Read More
Potential for new handle on treating cancer by harnessing Natural Killer cells
Sep 10, 2013
Mammals contain cells whose primary function is to kill other cells in the body. The so-called Natural Killer (NK) cells are highly important in defending our bodies against viruses or even cancer. Scientists at the University of Veterinary Medicine, Vienna (Vetmeduni Vienna) provide evidence that NK cell activity can be influenced by phosphorylating a protein (STAT1) in NK cells... Read More
Previous Page Next Page